Replay available: Webinar on microvascular AO imaging

 

On March 28, 2022, we had the pleasure to interview 3 clinical experts about the use of adaptive optics (AO) in diseases that alter small blood vessels.

Michel Paques, Daniela Castro Farias and Antonio Gallo explained why they started looking into retinal vessels with rtx1 AO cameras. They shared findings in patients with diabetes, vasculitis and hypertension, and even gave precious advice on imaging protocols. Finally, they discussed why they consider AO imaging a valuable tool for assessing natural disease progression, response to treatments, and retinal function.

We are grateful to them for sharing their vision during this webinar.

If you missed it, click the video above to watch the replay.

 

 

About our guests

Michel Paques, MD-PhD, is professor of ophthalmology and researcher at Quinze Vingts National Ophthalmology Hospital and  Vision Institute, Paris. His focus is on medical applications of high resolution in vivo retinal imaging in humans. He pioneered the development of cell-specific imaging using SLO, and the application of adaptive optics ophthalmoscopy for a variety of retinal diseases.

Antonio Gallo, MD-PhD, is a doctor in internal medicine at Pitié-Salpêtrière Hospital, Paris, and researcher in the field of cardiovascular prevention. His research is focused on translational approaches for improving cardiovascular risk prediction. This involves genomics, proteomics and non-invasive vascular imaging. For his PhD thesis he studied retinal microvascular remodeling in cardiometabolic disease.

Daniela Castro-Farias, MD-MSc, is an ophthalmologist with a clinical and surgical retina specialty who graduated from Instituto de Oftalmología Conde de Valenciana, Mexico City. She currently works at Quinze Vingts National Ophthalmology Hospital in Paris. Her recent projects involved adaptive optics retinal imaging for neurovascular coupling assessment in Cadasil patients.